You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
At-Home Minimally Invasive Tacrolimus Plasma Level Monitoring Device
SBC: REAL-TIME ANALYZERS INC Topic: A18145The overall goal of this proposed project (through Phase III) is to develop the Tacrolimus At-home Saliva Test (TAST) to measure tacrolimus at ng/mL levels in oral fluid (saliva) at-home in 15-20 minutes. The TAST will replace the painful blood tests currently performed at hospital and clinics that military patients, who have limb, facial and organ transplants, must undergo to avoid transplant r ...
SBIR Phase II 2023 Department of DefenseDefense Health Agency -
Development of Human Monoclonal Antibody Therapeutic Against Klebsiella pneumoniae Infection
SBC: Technology Holding, LLC Topic: DHA202003Antibiotic resistant infections are a principal concern for the Department of Defense and society at large due to the current lack of available treatments. Monoclonal antibodies represent a promising drug class that could be applied to antibiotic resistant infections to harness a patients own immune system to effectively combat the invading threat. In this program we continue program development t ...
SBIR Phase II 2023 Department of DefenseDefense Health Agency -
Ultrasonic-Guided Femoral Dual Lumen Cannula for Veno-Venous Extracorporeal Life Support
SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC. Topic: DHA231003The major limitations for the use of ECLS in the far-forward environment are the difficulty of its initiation, the need to adjunctive imaging to avoid damage to the heart and great vessels, and difficulty confirming correct cannula placement both in the far-forward and the transport environments. Thus, our proposed study will design and test two highly innovative features that will directly addre ...
SBIR Phase I 2023 Department of DefenseDefense Health Agency -
Biomimetic Slope Adaptive Foot-Ankle Prosthesis
SBC: MOTION CONTROL, INC Topic: DHP16C007The primary objectiveis to develop acommercially-viable prototype of theslopeadaptive prosthesis design and to iteratively improvethe design based on ISO standards testingand rigorous usein human subject field trials. The proposed work will build upon knowledgegained in PhaseI of the project,which established feasibility for this design approach in alightweight, passive hydraulicfoot-anklesystem. ...
STTR Phase II 2022 Department of DefenseDefense Health Agency -
Measuring Stormwater Overflow with Synthetic Aperture Radar
SBC: WOLVERINE RADAR COMPANY Topic: 93Many municipalities in the United States have begun to use impermeability measurements to incentivize storm water retention as part of the architectural and landscaping design process. These measurements are performed through analysis of high-resolution aerial photography and updated on an annual or semi-annual basis. The practice of using high resolution aerial or even satellite photography is pr ...
SBIR Phase I 2022 Department of CommerceNational Oceanic and Atmospheric Administration -
Medical Sterilizer for Far Forward Austere Environments
SBC: Technology Holding, LLC Topic: DHA213006The current steam based sterilizers have weight and power related challenges that limits their use to Role 3 environments. Further, due to high temperature of use, these are unsuitable for non-metallic objects such as medical scopes. The proposing team will develop a sterilizer for far forward austere Role 2 environments. The sterilizer uses modalities such that it can be used for sterilization of ...
SBIR Phase I 2022 Department of DefenseDefense Health Agency -
Multi-Mode Exoskeleton Boot to Facilitate Rehabilitation and Return to Service
SBC: RESULTS GROUP, LLC Topic: DHA224D003More than half of military service members sustain a musculoskeletal injury each year, and the majority of those are attributed to the lower limb, leading to millions of days of limited duty annually and reduced overall readiness. To establish a leadership role, a solution will help strengthen holistic continuity of care across the phases of lower limb rehabilitation and enhance prevention, whil ...
SBIR Phase II 2022 Department of DefenseDefense Health Agency -
Novel Biologic Countermeasure for Acute Radiation Syndrome
SBC: Technology Holding, LLC Topic: DHA201002Acute Radiation Syndrome (ARS) is an acute illness caused by irradiation of a significant portion of the body by a high dose of ionizing radiation (IR) in a short period of time. Global proliferation of radioactive and nuclear materials has resulted in increased threat of weaponized exposure or inadvertent exposure resulting from industrial accidents such as the case with the Chernobyl Nuclear Pow ...
SBIR Phase II 2022 Department of DefenseDefense Health Agency -
Combat Casualty Automated Trainer (C-CHAT)
SBC: SOAR TECHNOLOGY INC Topic: DHA17B001This expansion effort will enable SoarTech to harden the C-CHAT prototype for use during field exercises and increase the current 4 TRL to a 7 TRL. Working with partners at the USMC Field Medical Training Battalion (FMTB) and the University of Central Florida (UCF), we will enhance C-CHAT to run as a stand-alone application on a DoD-approved Android smartphone (e.g., the Samsung Galaxy S20 Tactica ...
STTR Phase II 2021 Department of DefenseDefense Health Agency -
Development of Human Monoclonal Antibody Therapeutic against Klebsiella pneumoniae Infection
SBC: Technology Holding, LLC Topic: DHA202003Antibiotic resistant infections are a principal concern for the Department of Defense and society at large due to the current lack of available treatments. Monoclonal antibodies represent a promising drug class that could be applied to antibiotic resistant infections to harness a patients own immune system to effectively combat the invading threat. In this program we present an optimized workflow ...
SBIR Phase I 2021 Department of DefenseDefense Health Agency